COVID-19

Here’s the last roundup of the latest coronavirus-related news in 2020.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event on the disproportionate impact of COVID-19 among racial and ethnic minority groups.

Our latest podcast episode discusses how pharmacies can tap technology to boost vaccination programs for COVID-19 vaccines and others.

The FDA has authorized the Moderna mRNA vaccine for emergency use, making it the second vaccine for COVID-19.

Here’s a roundup of the latest coronavirus-related news.

US health care workers have started receiving the COVID-19 vaccine, but we are still months away from approving the vaccine for use in children, according to Fauci.

This week, members of the MJH Life Sciences COVID-19 Coalition shared insights on the latest pandemic news, including long-term health consequences, vaccine hesitancy, and new recommendations.

In a session held during ASHP Midyear 2020 Clinical Meeting & Exhibition, Anthony Fauci, MD, warned pharmacists of challenging months ahead amid the COVID-19 pandemic.

The FDA has granted emergency use authorization (EUA) to the Pfizer/BioNTech COVID-19 vaccine.

Here’s a roundup of the latest coronavirus-related news:

The FDA is not required to follow the committee's advice, but it is expected to do so.

Pharmacists can prepare themselves to address patients’ questions and concerns about the COVID-19 vaccines.

Here’s a roundup of the latest coronavirus-related news.

Pharmacists may be among the first of the prioritized groups to be offered the COVID-19 vaccine once it receives FDA authorization.

CVS Health will pilot the administration of a limited supply of the monoclonal antibody therapy bamlanivimab to eligible patients at home or in long-term care facilities.

A survey conducted by the American Pharmacists Association asked pharmacists if they were ready to receive and administer COVID-19 vaccines.

The first doses of the mRNA COVID-19 vaccine will be delivered in the UK in the next few days, Pfizer announced.

Moderna reported an efficacy rate of 94.1% for its COVID-19 vaccine based on the primary efficacy analysis.

A recent study showed “alarming” rates of reported loneliness, anxiety, depression, and substance use in young adults during COVID-19.

Here’s a roundup of this week’s coronavirus-related news.

A study to be presented at the annual meeting of the Radiological Society of North America reported that COVID-19 patients with diabetes and hypertension may have a higher risk for neurologic complications.

As coronavirus disease 2019 (COVID-19) cases rise across the country, members of the MJH Life Sciences COVID-19 Coalition shared their perspectives on pandemic containment efforts.

Infectious Disease Society of America offered a look at the current treatment options for COVID-19 and stressed the need to maintain precautions to keep people safe.

One vaccine dosing regimen for AZD1222 showed 90% efficacy, according to investigators at the University of Oxford.

Here's the roundup of this week's coronavirus-related news.